Viking Therapeutics VKTX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's investment purchases?
- Viking Therapeutics (VKTX) reported investment purchases of $72.44M in Q1 2026.
- How has Viking Therapeutics's investment purchases changed year-over-year?
- Viking Therapeutics's investment purchases decreased by 68.9% year-over-year, from $232.61M to $72.44M.
- What is the long-term trend for Viking Therapeutics's investment purchases?
- Over 4 years (2021 to 2025), Viking Therapeutics's investment purchases has grown at a 25.6% compound annual growth rate (CAGR), from $168.02M to $418.04M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.